Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Medeva's Hepagene study shows promising results as treatment of chronic HBV

Jan. 21, 2000

Enzo Biochem receives grant for HBV therapy

Jan. 19, 2000

Partners lay the groundwork to begin clinical testing of novel anti-HCV agent

Jan. 18, 2000

Carrington completes enrollment for phase III trial of ulcerative colitis treatment

Jan. 14, 2000

Preparation, biological activity and use of neurokinin antagonists reported by Sanofi-Synthelabo

Jan. 13, 2000

Synsorb Cd receives fast track designation from FDA for CDAD treatment

Jan. 13, 2000

IL-1/TNF-alpha suppressant ameliorates intestinal ischemia-reperfusion injury in dogs

Jan. 13, 2000

Second pivotal phase III trial of adefovir dipivoxil as HBV treatment initiated

Jan. 12, 2000

Adult patients with chronic liver disease respond poorly to HBV vaccines

Jan. 10, 2000

BLA submitted for PEG-Intron HCV therapy

Jan. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...